Skip to main content
Padgett Medical Center

Peptide quality ยท Updated November 2026

Research Peptides vs Pharmacy-Compounded Peptides

Peptides sold online as "research grade" and peptides prescribed at a medical practice can share a name and look alike in a vial. They are not the same thing. Here is the difference, what the FDA and HHS have said about it, and what testing has found, with every source linked.

Peptide quality

The short version

At Padgett Medical Center in Tampa, peptides are prescribed only after a consultation with a licensed medical provider, and each one is compounded for the individual patient by a licensed U.S. compounding pharmacy. That is not the same as the "research grade" or "research use only" peptides sold online, which are labeled not for human use and are not made or checked to pharmacy standards for people, so there is no way to be sure of their strength, purity or sterility, or how well they will work.

Prescribed, pharmacy-compounded peptides at Padgett Medical Center compared with research-grade peptides sold online
Prescribed and pharmacy-compounded at PadgettResearch-grade / research use only
Who decides it's right for you
A licensed provider reviews your health history at a free consultation before anything is prescribed.No one. You pick a vial from a website.
Where it's made
A licensed U.S. compounding pharmacy, made for you to a prescription.Unknown manufacturers, often overseas, selling "for research use only".
Meant for people?
Yes. Compounded for a named patient to take.No. Labeled not for human use or consumption.
Strength, purity and sterility
Held to pharmacy compounding standards.Not verified to pharmacy standards, so the dose and what else is in the vial are unknown.
Support while you take it
Tell your provider about any side effect or question while you take it; they can adjust your plan.You're on your own.
Price
Published on every peptide page, and the consultation is free.Cheap per vial, but you can't know what you're paying for.

What are research peptides?

Research peptides are peptide powders and liquids sold online as "research grade", "research use only" or "not for human consumption". They are labeled not for human use, no one prescribes them, and they are not made or checked to pharmacy standards for people. A 2026 review of online "biohacking" peptide use described consumers using products "of uncertain identity, purity, potency, sterility, and safety" outside clinical supervision (Hailu et al., Cureus 2026).

Many sellers offer bacteriostatic water and syringes alongside them. FDA counts that as evidence the products are meant to be injected into people (FDA warning letter to Prime Sciences, March 31, 2026; Peak Performance Peptides, August 24, 2026).

What the FDA says about "research use only" labels

FDA's position is that the label does not change what a product is. In its 2026 warning letters to online peptide sellers, FDA wrote that "evidence obtained from your website establishes that your products are intended to be drugs for human use" and called the products unapproved new drugs. Letters went out on March 31, June 17 and August 24, 2026 (Prime Sciences; Wholesale Peptide; Peptide Partners).

The same letters warn that "injectable drug products can pose risks of serious harm to users", because injection bypasses some of the body's key defenses against toxins and microorganisms. For BPC-157 specifically, FDA's June 2023 warning letter covered injectable and nasal-spray BPC-157 labeled "research purpose only" and found the products were unapproved new drugs (Warrior Labz SARMS, June 12, 2023).

What testing has found

A 2026 preprint, which has not been peer reviewed, analyzed 6,441 samples of gray-market "research" peptides across 14 compounds, including BPC-157 and TB-500, from a public independent testing dataset. Depending on the quality standard applied, 41.6% to 71.1% of samples failed basic quality criteria, and 15% had measurable endotoxin contamination. The authors note that this kind of consumer testing "captures only a small fraction of the safety profile" that matters to people injecting these products (Mendias and Awan, 2026 preprint).

FDA's 2026 review of BPC-157 describes a woman who used a BPC-157 and TB-500 injectable labeled "for research purposes only" and developed diffuse darkening of the skin and gums, which came back when she used it again. The same review found that most certificates of analysis for BPC-157 ingredients include only a purity test (FDA briefing document on BPC-157, July 2026).

Belgium's public health institute found haemolytic Bacillus cereus bacteria in 2 illegal injectable peptide drugs (Janvier et al., 2018). A separate study identified Semax and Selank in seized preparations and found them sold online as "research peptides", as powders for injection or nasal sprays (Vanhee et al., 2020).

A related peer-reviewed study tested a different drug, semaglutide, bought from illegal online pharmacies: every sample was judged probably substandard or falsified, with measured purity of 7.7% to 14.37% against the 99% claimed and endotoxin in every sample (Ashraf et al., 2024). Those numbers are for semaglutide, not for the peptides on this site.

What the October 2026 HHS policy says, and what it does not

On October 30, 2026, HHS published a notice in the Federal Register about an interim policy for compounding six peptides: BPC-157, TB-500, KPV, MOTS-c, Semax and Epitalon. It says HHS does not intend to take enforcement action against state-licensed pharmacies and licensed physicians that compound them for individual patients while the FDA completes formal rulemaking, if conditions are met: a prescription for each patient, a bulk ingredient from an FDA-registered manufacturer with a certificate of analysis covering identity, purity, strength and contaminants, one peptide per product, only the forms the policy lists for each peptide, and reporting serious side effects to the FDA.

HHS said it acted partly to "discourage the continued, widespread use of certain peptides often labeled as research use only" and offered compounding as "a more controlled alternative" (Holland & Knight; RAPS). The policy does not cover products sold as research chemicals or dietary supplements. The notice itself states that compounded drugs are not FDA-approved. The notice announced the policy as a draft, open for public comment into mid-November 2026, and the policy is temporary and may change.

How Padgett Medical Center handles peptides

Padgett Medical Center in Tampa, Florida offers BPC-157, TB-500, KPV, MOTS-c, Semax and Epitalon, prescribed after a free consultation with a licensed provider and compounded by a licensed U.S. compounding pharmacy.

  • Every peptide is prescribed only after a free consultation with a licensed provider who reviews your health history and medicines.
  • Each peptide is compounded for you, the named patient, by a licensed U.S. compounding pharmacy. About our partner pharmacies.
  • One peptide per product. No blends.
  • Every product's price is published, and you only pay for the peptides you start.
  • Questions or side effects while you take it go to your provider, who can adjust your plan.
  • Compounded peptides have not been approved by the FDA. Benefits are possibilities, not promises.

Questions to ask before you take any peptide

  • Was it prescribed for me after a consultation with a licensed provider?
  • Was it compounded by a licensed pharmacy, for me by name?
  • Is it a single peptide, not a blend?
  • Does the label say it is for research use only or not for human consumption? If so, it is not meant for people.
  • Who do I call about a side effect or a question while I take it?

Research peptides: questions, answered

What are research peptides?

Research peptides are peptides sold online as "research grade", "research use only" or "not for human consumption". They are labeled not for human use, no one prescribes them, and they are not made or checked to pharmacy standards for people, so their strength, purity and sterility are unknown.

Are research peptides safe for humans?

There is no way to be sure. They are not made or checked to pharmacy standards for people. A 2026 preprint (not peer reviewed) found that 41.6% to 71.1% of gray-market research peptide samples failed basic quality criteria and 15% had measurable endotoxin, and FDA warns that injectable drug products can pose risks of serious harm.

What does "not for human consumption" mean on peptides?

It means the seller says the product is not meant to be taken by people. FDA has said the label does not settle the question: in 2026 warning letters it found that evidence on sellers' websites showed the products were intended as drugs for human use, and called them unapproved new drugs.

Are research peptides legal in the USA?

FDA has sent warning letters to online sellers of "research use only" peptides, calling the products unapproved new drugs when the evidence showed they were meant for people. The October 2026 HHS interim policy covers compounding of six peptides by licensed pharmacies for individual patients with a prescription; it does not cover products sold as research chemicals or supplements.

What is the difference between research peptides and compounded peptides?

At Padgett Medical Center in Tampa, peptides are prescribed only after a consultation with a licensed medical provider, and each one is compounded for the individual patient by a licensed U.S. compounding pharmacy. That is not the same as the "research grade" or "research use only" peptides sold online, which are labeled not for human use and are not made or checked to pharmacy standards for people, so there is no way to be sure of their strength, purity or sterility, or how well they will work.

Are compounded peptides FDA-approved?

No. Compounded peptides are not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness or quality before they are prescribed. The HHS interim policy is enforcement discretion, not an approval.

Is it legal to buy peptides online?

A compounded peptide is a prescription medication: it needs a prescription from a licensed prescriber and should come from a state-licensed pharmacy. Websites selling peptides labeled "research use only" have received FDA warning letters. For a related class of drugs, unapproved GLP-1 products, FDA's consumer advice is to buy only from state-licensed pharmacies.

Do I need a prescription for peptides?

For a compounded peptide, yes. The HHS interim policy covers compounding for individual patients with a prescription. At Padgett Medical Center, every peptide is prescribed by a licensed provider after a free consultation.

What is the HHS peptide compounding policy?

On October 30, 2026, HHS published a notice in the Federal Register about an interim enforcement discretion policy for six peptides: BPC-157, TB-500, KPV, MOTS-c, Semax and Epitalon. While the FDA completes rulemaking, HHS says it does not intend to take enforcement action against state-licensed pharmacies and licensed physicians that compound them for individual patients, if conditions are met. It was released as a draft for public comment, it is temporary and may change, and it is not an FDA approval.

Sources

  1. Federal Register: notice of the HHS interim policy on 503A compounding of certain peptides, 91 FR 68526 (October 30, 2026), FR Doc. 2026-22192
  2. FDA warning letter: Lovega LLC dba Pink Pony Peptides, March 31, 2026
  3. FDA warning letter: Prime Sciences, March 31, 2026
  4. FDA warning letter: Wholesale Peptide, June 17, 2026
  5. FDA warning letter: Peptide Partners LLC, August 24, 2026
  6. FDA warning letter: Royal Peptides LLC, August 24, 2026
  7. FDA warning letter: Peak Performance Peptides, August 24, 2026
  8. FDA warning letter: Warrior Labz SARMS (BPC-157), June 12, 2023
  9. FDA: Certain bulk drug substances for use in compounding that may present significant safety risks (content current April 22, 2026)
  10. FDA briefing document: BPC-157-related bulk drug substances, Pharmacy Compounding Advisory Committee, July 23-24, 2026
  11. FDA: FDA's concerns with unapproved GLP-1 drugs used for weight loss (content current October 1, 2026)
  12. Holland & Knight: HHS issues interim enforcement discretion policy for compounding of 6 peptides (November 4, 2026)
  13. RAPS: HHS will permit compounding of six peptides ahead of formal rulemaking (October 29, 2026)
  14. NPR via WGCU: Trump administration will allow pharmacies to make popular peptides (October 28, 2026)
  15. Mendias CL, Awan TM. Evaluation of research grade peptides marketed directly to consumers. Preprints.org, April 24, 2026 (preprint, not peer reviewed)
  16. Ashraf AR, et al. Multifactor quality and safety analysis of semaglutide products sold by online sellers. J Med Internet Res, 2024 (PMID 39509151)
  17. Janvier S, et al. Are injectable illegal polypeptide drugs safe? Haemolytic Bacillus cereus in 2 illegal peptide drugs. Drug Testing and Analysis, 2018 (PMID 28941153)
  18. Vanhee C, et al. Cognitive enhancing research peptides (Semax, Selank) in seized preparations. Drug Testing and Analysis, 2020 (PMID 31667971)
  19. Hailu KT, et al. Unregulated peptide use in the age of biohacking. Cureus, 2026 (PMID 42437212)

Free peptide consultation

Talk with a licensed provider before you take any peptide

The consultation is free. You only pay for your peptides if you start. In person at our Tampa clinic or by telehealth anywhere in Florida, and new patients who book online with a card on file get 10% off their first peptide order.

* Compounded peptides have not been approved by the FDA. They have not been reviewed by the FDA for safety, effectiveness or quality, and none of the peptides on this site is an FDA-approved drug. The benefits described are possibilities from research, not promises, and results vary from person to person. A licensed provider decides at your consultation whether a peptide is right for you. This page is educational and is not medical advice.

Call NowBook